Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.290
+0.010 (0.30%)
At close: Feb 20, 2026, 4:00 PM EST
3.360
+0.070 (2.13%)
After-hours: Feb 20, 2026, 7:29 PM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $341.74 million as of February 20, 2026. Its market cap has increased by 5.90% in one year.
Market Cap
341.74M
Enterprise Value
210.09M
1-Year Change
5.90%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $341.74M, an increase of 104.63%. That is a compound annual growth rate of 14.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 314.80M | 43.88% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 363.29M |
| LENZ Therapeutics | 362.65M |
| Nautilus Biotechnology | 356.18M |
| Aclaris Therapeutics | 351.04M |
| Puma Biotechnology | 344.17M |
| Aura Biosciences | 343.55M |
| Cybin | 340.74M |
| Vanda Pharmaceuticals | 340.46M |